0001144204-17-035031.txt : 20170629
0001144204-17-035031.hdr.sgml : 20170629
20170629210114
ACCESSION NUMBER: 0001144204-17-035031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170627
FILED AS OF DATE: 20170629
DATE AS OF CHANGE: 20170629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fundaro Paolo
CENTRAL INDEX KEY: 0001559537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 17940007
MAIL ADDRESS:
STREET 1: C/O GENEXTRA S.P.A.,
STREET 2: VIA G. DE GRASSI, 11
CITY: MILAN
STATE: L6
ZIP: 20123
4
1
v470072_form4.xml
FORM 4
X0306
4
2017-06-27
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001559537
Fundaro Paolo
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
1
0
0
0
Common Stock
2017-06-27
4
A
0
1423
0
A
11498
D
Option to Purchase Common Stock
122.01
2017-06-27
4
A
0
2036
0
A
2027-06-27
Common Stock
2036
2036
D
The 1,423 shares of restricted stock and the shares of 2,036 shares of common stock underlying the option will each fully vest on the one-year anniversary of the date of grant (the "Anniversary Date"), subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the "2012 Plan"); provided, however, if the date of the next subsequent annual meeting of stockholders (starting from the 2018 annual meeting) is held prior to the Anniversary Date in that year, the annual vesting for such year shall occur on the day immediately preceding the date of the annual meeting in such year.
/s/ Bryan Yoon, as attorney-in-fact
2017-06-29